BADARINADH GUPTA PERURI
Articles written in Journal of Chemical Sciences
Volume 132 All articles Published: 13 February 2020 Article ID 0042
Synthesis of metabolites of dapagliflozin: an SGLT2 inhibitor
KISHORE KARUMANCHI SENTHIL KUMAR NATARAJAN RAMADAS CHAVAKULA RAGHU BABU KORUPOLU KISHORE BABU BONIGE BADARINADH GUPTA PERURI
Dapagliflozin is one of the gliflozin class drugs, useful for the treatment of type-2 diabetes. Dapagliflozin undergoes extensive metabolism and transforms to metabolites in humans. The contribution of pharmacologically active metabolites in drug discovery and development is significant. A streamlined synthetic approach is devised to access three metabolites of dapagliflozin namely, benzylic hydroxy dapagliflozin, oxo dapagliflozin and desethyl dapagliflozin.Two synthetic protocols have been proposed for the synthesis of benzylic hydroxy dapagliflozin and oxo dapagliflozin. An enantioselective deethylation of dapagliflozin is also reported
Volume 135, 2023
All articles
Continuous Article Publishing mode
Click here for Editorial Note on CAP Mode
© 2023-2024 Indian Academy of Sciences, Bengaluru.